# Pilot Study of Azficel-T for the Treatment of Restrictive Burn Scars

> **NCT01858753** · PHASE2 · TERMINATED · sponsor: **Castle Creek Biosciences, LLC.** · enrollment: 5 (actual)

## Conditions studied

- Restrictive Burn Scars

## Interventions

- **BIOLOGICAL:** Autologous fibroblasts
- **BIOLOGICAL:** placebo sterile saline

## Key facts

- **NCT ID:** NCT01858753
- **Lead sponsor:** Castle Creek Biosciences, LLC.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2013-05
- **Primary completion:** 2016-05
- **Final completion:** 2016-07
- **Target enrollment:** 5 (ACTUAL)
- **Why stopped:** unable to enroll
- **Last updated:** 2021-10-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01858753

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01858753, "Pilot Study of Azficel-T for the Treatment of Restrictive Burn Scars". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01858753. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*